North American Market Commanded the Largest Share of 45.1% of the Global Glaucoma Surgery Device Market

Date: 2015-08-17

“The global glaucoma surgery devices market is estimated to grow at a CAGR of 8.4% from 2014 to 2019. The North American region accounted for the largest share of this market, and is projected to grow at a CAGR of 7.8% during the given forecast period. The glaucoma surgery device market holds a high potential for growth in the coming years owing to the increasing strategic expansion of companies, the growing aging population, and the rising incidence of eye disorders. However, general lack of awareness among people about eye disorders and poor primary healthcare infrastructure, along with lack of healthcare insurance, are the major factors that may restrain the growth of the global glaucoma surgery device market in the coming years.

In this report, the glaucoma surgery devices market has been broadly classified on the basis of end-user, type, and geography. 

Geographically, the market has been segmented into North America, Europe, Asia, and Rest of the World (RoW), wherein the North American market commanded the largest share of 45.1% of the global glaucoma surgery device market in 2014, followed by the European market. 

The report has profiled the leading players of this market, along with the developments (new product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the global glaucoma surgery device market.

The key players in the global glaucoma surgery device market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and Iridex Corporation (U.S.).


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample